| Q35101462 | A role for peroxisome proliferator-activated receptors in the immunopathology of schistosomiasis? |
| Q28728933 | A simplified, sensitive phagocytic assay for malaria cultures facilitated by flow cytometry of differentially-stained cell populations |
| Q44620791 | Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages |
| Q37584947 | Are reactive oxygen species always detrimental to pathogens? |
| Q34521530 | CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum |
| Q46922559 | Comparability of Inflammation-Adjusted Vitamin A Deficiency Estimates and Variance in Retinol Explained by C-Reactive Protein and α1-Acid Glycoprotein during Low and High Malaria Transmission Seasons in Rural Zambian Children |
| Q40403699 | Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia |
| Q41843436 | Direct activation of human endothelial cells by Plasmodium falciparum-infected erythrocytes |
| Q30336129 | Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. |
| Q64242212 | Effect of on the Hepatic Oxidative Status and Expression of Inflammatory and Apoptotic Genes during Blood-Stage Murine Malaria |
| Q36292400 | Effect of vitamin A adjunct therapy for cerebral malaria in children admitted to Mulago hospital: a randomized controlled trial |
| Q55215396 | Elevated plasma abscisic acid is associated with asymptomatic falciparum malaria and with IgG-/caspase-1-dependent immunity in Plasmodium yoelii-infected mice. |
| Q34931884 | Emerging roles of PPARs in inflammation and immunity |
| Q34622540 | Endotoxaemia is common in children with Plasmodium falciparum malaria |
| Q27486399 | Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals |
| Q46222698 | Evaluating anti-disease immunity to malaria and implications for vaccine design. |
| Q38515042 | Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria |
| Q38484575 | Fatty acids from Plasmodium falciparum down-regulate the toxic activity of malaria glycosylphosphatidylinositols |
| Q40141303 | IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. |
| Q34973764 | Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides. |
| Q34712677 | Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells |
| Q39446916 | Mechanism of protection induced by vitamin A in falciparum malaria |
| Q35927561 | Modulation of macrophage efferocytosis in inflammation |
| Q42258999 | Nonopsonic phagocytosis of erythrocytes infected with ring-stage Plasmodium falciparum |
| Q34031187 | Nrf2, a PPARγ alternative pathway to promote CD36 expression on inflammatory macrophages: implication for malaria |
| Q36073865 | Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria |
| Q43974270 | PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. |
| Q26771755 | PPARγ and the Innate Immune System Mediate the Resolution of Inflammation |
| Q88550338 | PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice |
| Q33335133 | Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. |
| Q38192001 | Parasitic diseases in travelers: a focus on therapy |
| Q40582700 | Peroxisome Proliferator-Activator Receptor γ: A Link between Macrophage CD36 and Inflammation in Malaria Infection |
| Q37817830 | Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy |
| Q37695084 | Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections |
| Q40995222 | Peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists have minimal effects on the interaction of endothelial cells with Plasmodium falciparum-infected erythrocytes |
| Q35854390 | Polysaccharides from the Chinese medicinal herb Achyranthes bidentata enhance anti-malarial immunity during Plasmodium yoelii 17XL infection in mice |
| Q40376689 | Recruited monocytes modulate malaria-induced lung injury through CD36-mediated clearance of sequestered infected erythrocytes. |
| Q35679569 | Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo |
| Q40206336 | Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica |
| Q39446904 | Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria |
| Q33721892 | Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria |
| Q29396069 | Sequestration and Tissue Accumulation of Human Malaria Parasites: Can We Learn Anything from Rodent Models of Malaria? |
| Q33842019 | Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome |
| Q36958477 | Supplementation with Abscisic Acid Reduces Malaria Disease Severity and Parasite Transmission |
| Q27693193 | TH1/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism? |
| Q35101529 | The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria |
| Q34687796 | The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria |
| Q36727337 | Vitamin and cofactor biosynthesis pathways in Plasmodium and other apicomplexan parasites |